Description
FORMA FARMACÉUTICA: 50 TABLETAS
Características de MENIROL:
un inhibidor de CDK4/6 usado en el tratamiento de cáncer de mama avanzado o metastásico en combinación con terapia endocrina en pacientes adultos
TOUJEO 300 U/ML | Solución Inyectable | Plumas Prellenadas 3 × 1
hematológica y neurológica
DERMATOVATE CMA. 0.044 G. CAJA C/TUBO C/40 G. MINERAL OIL FORMA FARMACÉUTICA: 50 TABLETASSUSTANCIA: DERMATOVATE CMA. 0. 044 G. CAJA C TUBO C 40 G. FABRICANTE: GLAXO SMITH KLINE
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
